Efficacy and safety of 300IR 5-grass pollen sublingual allergen immunotherapy tablets in us adults with grass-pollen allergic rhinoconjunctivitis

Authors
Category Primary study
JournalWorld Allergy Organization Journal
Year 2012
This article has no abstract
Epistemonikos ID: aed10fc93ac0f3e63cdaae413d27dba64210b0a7
First added on: Feb 05, 2025